Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, British Columbia, Oct. 06, 2023 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at Jefferies Inaugural Biotech CNS/Neuro Summit to be held on October 11, 2023.

Company Fireside Chat Presentation Details:

Date: Wednesday, October 11, 2023
   
Time: 2:25 PM Eastern Time
   
Webcast: Register here
   
Presenters: Ian Mortimer, President and Chief Executive Officer
Sherry Aulin, Chief Financial Officer
   

A live webcast of the company presentation will be available on the “Investors” section of Xenon’s website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: (604) 484-3353
Email: investors@xenon-pharma.com

Staff

Recent Posts

Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products

Winter Park, Florida--(Newsfile Corp. - February 18, 2025) - Adia (OTC Pink: ADIA) Med is…

5 minutes ago

Healing Realty Trust Announces Acquisition of Medical Plaza in Oak Lawn, IL

Jupiter, Florida--(Newsfile Corp. - February 18, 2025) - Healing Realty Trust Inc. ("Healing Realty Trust",…

5 minutes ago

Promino Nutritional Sciences Inc. Partners with Fastbreak AI and Provides Corporate Update

Burlington, Ontario--(Newsfile Corp. - February 18, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC…

1 hour ago

Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE:…

2 hours ago

Astrana Health, Inc. Schedules 2024 Fourth Quarter and Full Year Financial Results Release and Conference Call

ALHAMBRA, Calif., Feb. 17, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its…

14 hours ago

Hormonal Health Stigma Keeps 68% of Women From Seeking Help – Sex Hormones Awareness Week 2025 Calls for Change

As part of the initiative, the company released a comprehensive report on the State of…

14 hours ago